Prognostic significance of cutaneous immune-related adverse events in patients with melanoma and other cancers on immune checkpoint inhibitors-Reference-Cited by-同舟云学术

Prognostic significance of cutaneous immune-related adverse events in patients with melanoma and other cancers on immune checkpoint inhibitors

Published:2021-03 Issue: Volume: Page:
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Thompson Leah L.,Chang Michael S.,Polyakov Nicole J.,Blum Amy E.,Josephs Nathaniel,Krasnow Nira A.,Yoon Jaewon,Li Edward B.,Molina Gabriel E.,Said Jordan T.,Huang Kevin,Kuchroo Juhi R.,Hinton Andrea N.,Chen Steven T.

Publisher

Elsevier BV

Subject

Dermatology

Reference5 articles.

1. Immune checkpoint inhibitor-related dermatologic adverse events;Geisler;J Am Acad Dermatol,2020

2. Correlation between cutaneous adverse events and prognosis in patients with melanoma treated with nivolumab: a single institutional retrospective study;Nakano;J Dermatol,2020

3. Characterization of dermatitis after PD-1/PD-L1 inhibitor therapy and association with multiple oncologic outcomes: a retrospective case-control study;Min Lee;J Am Acad Dermatol,2018

4. Association of immune-related adverse events with nivolumab efficacy in non-small-cell lung cancer;Haratani;JAMA Oncol,2018

5. Treatment outcomes of immune-related cutaneous adverse events;Phillips;J Clin Oncol,2019

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Associations between dermatologic immune-related adverse event morphologies and systemic immunomodulatory/immunosuppressive treatment: A large retrospective cohort study;Journal of the American Academy of Dermatology;2024-06

2. Characterization and Prognostic Significance of Cutaneous Immune-Related Adverse Events in Indian Patients on Immune Checkpoint Inhibitor Therapy;Dermatology Practical & Conceptual;2023-07-31

3. Autoimmune bullous dermatoses in cancer patients treated by immunotherapy: a literature review and Italian multicentric experience;Frontiers in Medicine;2023-07-20

4. Immunotherapy for keratinocyte cancers. Part II: Identification and management of cutaneous side effects of immunotherapy treatments;Journal of the American Academy of Dermatology;2023-06

5. Cutaneous Adverse Reactions of Immunotherapy in Patients with Advanced Melanoma;Cancers;2023-03-31